Selecting NSCLC patients for erlotinib pays off in France Clinical study 14 January 2013 Pages: 1 - 1
Rotavirus vax should be “highly cost-effective” in Bolivia Clinical study 14 January 2013 Pages: 5 - 5
Anidulafungin cost effective despite high acquisition costs Clinical study 14 January 2013 Pages: 6 - 6
Skin test aids cost effectiveness of TB prevention in Botswana . . . Clinical study 14 January 2013 Pages: 7 - 7
CPM cost effective but tailored care important in breast cancer Clinical study 14 January 2013 Pages: 8 - 8
Lung cancer screening for older smokers likely to be cost effective Clinical study 14 January 2013 Pages: 8 - 8
Palivizumab proves too costly for RSV prevention in Canada Clinical study 14 January 2013 Pages: 9 - 9
Once daily asthma treatment should make $2 billion by 2019 Media release 14 January 2013 Pages: 10 - 10
Raloxifene, teriparatide and long-acting olanzapine funded by NZ Pharmac Media release 14 January 2013 Pages: 11 - 11